Mohamed Samir M.D. is a Vice President, Medical Affairs, Pharmacovigilance and Quality Assurance in NewBridge Pharmaceuticals. Mohamed Samir has over 23 years’ experience in Multinational Pharmaceuticals in the Middle East and Africa region, having worked previously in Medical Affairs, Clinical Research, Regulatory Affairs, Commercial, Public and Corporate Affairs. He previously held senior regional leadership roles in Medical and Regulatory Affairs in Eli Lilly and Mundipharma, as well as other roles in Wyeth Pharmaceuticals, Roche and Boehringer Ingelheim. Mohamed is a Medical Doctor, and graduated from Cairo University Medical School, Egypt.